关键词：康复技术；临床医学；免疫原；脊髓损伤
摘 要：We are one-year into the three-years of our research program into the immunogenetic and drug exposure factors that contribute to chronic pain following spinal cord injury. Owing to the planned data collection timeline of the 2 studies in this program we have no raw data to report, but we have made significant administrative advances. Study 1 comprises two study sites, South Australia (site 1) and New South Wales (site 2). We have received human research ethics approval from the Royal Adelaide Hospital (site 1) and the New South Wales approval is under review. Study 1 has been approved by the Human Research Protection Office (16986.1). Our clinical team at Site 1 (Hampstead Rehabilitation Centre, Royal Adelaide Hospital) has identified 244 patients in their database who fulfill the inclusion criteria for Study 1. They have been processing 20-30 recruitment and questionnaire/sample mail-outs per week. The aim is to have exhausted the Site 1 subject list by the end of 2012 and have begun Site 2 (NSW) recruitment in 2013. Study 2 institutional Ethics approval has been gained and is being reviewed by the Human Research Protection Office (16986.2). We are on track to start Study 2 in 2013 as planned.